Species: Human

Category: Cancer

Tissue of Origin: Lung

Cancer Type: Lung Carcinoma

Description

SK-LC-19 is a human lung cancer cell line.

Source

This cell line was established from a lung metastasis from a person with lung carcinoma.

Lead Researcher/Research Laboratory

• Lloyd J. Old, MD, former William E. Snee Chair in Cancer Immunology, MSK; former Director of the Ludwig Institute for Cancer Research

Key References

Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. U.S.A. 95:7556-7561(1998) (PubMed ID 9636188)

Licensing Information

This cell line may be licensed nonexclusively for research or commercial purposes.

• Express License: For internal research purposes by a for-profit entity: Fill out MSK’s Core Express License; see here for links to the online fillable Core Express License, as well as a PDF version. For detailed guidance on how to fill out this webform, see here. Please note:  In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. This license is only available for select cell lines, including this one. Once this license has been executed by MSK, you will receive a signed copy and payment instructions; all payments up to $10,000 must be made by credit card.
• Commercial License: Contact MSK’s Tangible Research Materials team at [email protected].
• For non-licensing requests from academic-research institutions: Contact MSK’s Antibody & Bioresource Core Facility at [email protected].